Immunogenicity and Safety of an Inactivated COVID-19 Vaccine for Prevention of COVID-19 in Healthy Population Aged 18 Years and Older
Latest Information Update: 18 Apr 2022
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary) ; Hepatitis A vaccine inactivated; Pneumococcal 23 valent vaccine Sinovac Biotech
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Sponsors Sinovac Biotech
- 12 Apr 2022 Status changed from recruiting to completed.
- 25 Jul 2021 Status changed from not yet recruiting to recruiting.
- 12 Jul 2021 New trial record